Literature DB >> 33834402

Genetic Architecture of Depression: Where Do We Stand Now?

Pinar Unal-Aydin1, Orkun Aydin1, Ayla Arslan2.   

Abstract

The research of depression genetics has been occupied by historical candidate genes which were tested by candidate gene association studies. However, these studies were mostly not replicable. Thus, genetics of depression have remained elusive for a long time. As research moves from candidate gene association studies to GWAS, the hypothesis-free non-candidate gene association studies in genome-wide level, this trend will likely change. Despite the fact that the earlier GWAS of depression were not successful, the recent GWAS suggest robust findings for depression genetics. These altogether will catalyze a new wave of multidisciplinary research to pin down the neurobiology of depression.

Entities:  

Keywords:  Association studies; Candidate genes; Depression; Depression genetics; GWAS; Genetics; Genome-wide association study

Mesh:

Year:  2021        PMID: 33834402     DOI: 10.1007/978-981-33-6044-0_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  115 in total

1.  Genetic epidemiology of major depression: review and meta-analysis.

Authors:  P F Sullivan; M C Neale; K S Kendler
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 3.  Stress, depression, and neuroplasticity: a convergence of mechanisms.

Authors:  Christopher Pittenger; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2007-09-12       Impact factor: 7.853

4.  The global burden of disease, 1990-2020.

Authors:  A D Lopez; C C Murray
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

Review 5.  New approaches to antidepressant drug discovery: beyond monoamines.

Authors:  Olivier Berton; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

Review 6.  Neurophysiology and Regulation of the Balance Between Excitation and Inhibition in Neocortical Circuits.

Authors:  Roberta Tatti; Melissa S Haley; Olivia K Swanson; Tenzin Tselha; Arianna Maffei
Journal:  Biol Psychiatry       Date:  2016-09-29       Impact factor: 13.382

Review 7.  The size and burden of mental disorders and other disorders of the brain in Europe 2010.

Authors:  H U Wittchen; F Jacobi; J Rehm; A Gustavsson; M Svensson; B Jönsson; J Olesen; C Allgulander; J Alonso; C Faravelli; L Fratiglioni; P Jennum; R Lieb; A Maercker; J van Os; M Preisig; L Salvador-Carulla; R Simon; H-C Steinhausen
Journal:  Eur Neuropsychopharmacol       Date:  2011-09       Impact factor: 4.600

8.  Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.

Authors:  Stefan M Gold; Mary-Frances O'Connor; Raja Gill; Kyle C Kern; Yonggang Shi; Roland G Henry; Daniel Pelletier; David C Mohr; Nancy L Sicotte
Journal:  Hum Brain Mapp       Date:  2012-07-30       Impact factor: 5.038

Review 9.  Neuroplasticity as a function of second language learning: anatomical changes in the human brain.

Authors:  Ping Li; Jennifer Legault; Kaitlyn A Litcofsky
Journal:  Cortex       Date:  2014-05-17       Impact factor: 4.027

10.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.